Percutaneous vertebral compression fracture management with polyethylene mesh-contained morcelized allograft bone.

Document Type

Article

Publication Date

6-1-2008

Comments

This article has been peer reviewed. It was published in: Current Reviews in Musculoskeletal Medicine.

Volume 1, Issue 2, June 2008, Pages 84-87.

The published version is available at DOI: 10.1007/s12178-007-9010-3. Copyright © Springer

Abstract

STUDY DESIGN: A comprehensive systematic review of the literature.

OBJECTIVES: To assess the modern literature on the use of polyethylene mesh-contained morcelized allograft (PMCMA) bone for spinal fusion and vertebral compression fracture management.

SUMMARY OF BACKGROUND DATA: There are presently no systematic reviews of PMCMA.

METHODS: A systematic literature review was performed within three databases (OVID, PubMed, and Google Scholar) using the following keyword search terms: vertebroplasty, kyphoplasty, vertebral compression fracture, percutaneous, polyethylene mesh, and osteoporosis.

RESULTS: The initial search identified 764 items, from which two pertinent technique-based articles were identified. There were no published scientific peer-reviewed or case series reporting the clinical results of this technique. The use of PMCMA in the management of vertebral compression fractures (VCFs) is similar to vertebroplasty and kyphoplasty. This novel, percutaneous system uses the properties of granular mechanics to establish a conforming, semirigid graft that is purportedly capable of withstanding physiologic loads.

DISCUSSION: PMCMA is a novel percutaneous technology for the management of VCF and possibly for use as a conforming interbody graft. The available published literature lacks outcome data of the use of PMCMA. Careful, independent research is needed to assess the viability of this technology and its long-term results.

PubMed ID

19468877

Link to Full Text

Share

COinS